05 September 2013

Almirall Launches New Affiliate in Canada

Toronto - 05 September 2013 – Barcelona-based Almirall has launched a new affiliate in Canada, the world’s seventh largest pharmaceutical market. Based in Mississauga, the Canadian affiliate will focus primarily on the respiratory and dermatology therapeutic areas. Almirall Canada is the company’s 14th affiliate joining affiliates across Europe and Mexico

General Manager for Almirall Canada, Ed Dybka, commented: “This is a very exciting time for Almirall. Pipeline advances, key regulatory milestones and collaboration agreements have set the stage for a period of sustained international growth. Our launch in Canada will contribute to this growth and emphasizes our commitment to the North American pharmaceutical market.”

The new affiliate will support the Canadian launches of new Almirall products including an innovative new treatment for chronic obstructive pulmonary disease (COPD), TudorzaTMGenuairTM,which will launch in the fall.

Almirall is a pharmaceutical company headquartered in Barcelona, Spain. With more than 3000 employees in 22 countries, Almirall generated total revenues that exceeded 1 billion dollars in 2012

Source: Almirall